Get the Stockscreener App
1.80
2.70%
-0.05
After Hours:
1.81
0.01
+0.56%
Entera Bio Ltd stock is traded at $1.80, with a volume of 100.97K.
It is down -2.70% in the last 24 hours and down -4.76% over the past month.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
See More
Previous Close:
$1.85
Open:
$1.85
24h Volume:
100.97K
Relative Volume:
0.80
Market Cap:
$82.19M
Revenue:
$134.00K
Net Income/Loss:
$-9.93M
P/E Ratio:
-5.2941
EPS:
-0.34
Net Cash Flow:
$-6.72M
1W Performance:
-12.62%
1M Performance:
-4.76%
6M Performance:
-9.09%
1Y Performance:
+0.00%
1-Day Range:
$1.80
$1.86
1-Week Range:
$1.80
$2.09
52-Week Range:
$1.5006
$2.79
Entera Bio Ltd Stock (ENTX) Company Profile
Name
Entera Bio Ltd
Sector
Industry
Phone
972-2-532-7151
Address
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Compare ENTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
1.80 | 84.93M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-22-21 | Initiated | Aegis Capital | Buy |
Entera Bio Ltd Stock (ENTX) Latest News
Published on: 2025-09-12 20:43:00 - Newser
Applying sector rotation models to Entera Bio Ltd.Quarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser
Short interest data insights for Entera Bio Ltd.2025 Geopolitical Influence & AI Enhanced Trading Signals - Newser
Is Entera Bio Ltd. trending in predictive chart models2025 Top Gainers & Fast Gain Stock Tips - Newser
Can Entera Bio Ltd. recover in the next quarterMarket Performance Recap & Technical Confirmation Trade Alerts - Newser
What technical models suggest about Entera Bio Ltd.’s comebackJuly 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser
Quantitative breakdown of Entera Bio Ltd. recent moveJuly 2025 Summary & Precise Trade Entry Recommendations - Newser
Will breakout in Entera Bio Ltd. lead to full recovery2025 Price Action Summary & Weekly Stock Performance Updates - Newser
What data driven models say about Entera Bio Ltd.’s futureJuly 2025 Volume & Weekly Market Pulse Alerts - Newser
Can a trend reversal in Entera Bio Ltd. lead to recoveryTrend Reversal & Daily Technical Forecast Reports - Newser
Technical signs of recovery in Entera Bio Ltd.Analyst Downgrade & Risk Managed Investment Signals - Newser
Full technical analysis of Entera Bio Ltd. stockAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
Why Entera Bio Ltd. is moving todayM&A Rumor & Fast Entry High Yield Stock Tips - Newser
Trend analysis for Entera Bio Ltd. this week2025 Key Lessons & High Accuracy Investment Signals - Newser
What moving averages say about Entera Bio Ltd.Market Activity Recap & Weekly Sector Rotation Insights - Newser
How to recover losses in Entera Bio Ltd. stock2025 EndofYear Setup & Risk Managed Investment Signals - Newser
Can volume confirm reversal in Entera Bio Ltd.Market Sentiment Report & Verified Swing Trading Watchlist - Newser
Using Python tools to backtest Entera Bio Ltd. strategiesJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat
Custom watchlist performance reports with Entera Bio Ltd.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser
Will Entera Bio Ltd. rebound enough to break evenQuarterly Profit Summary & High Accuracy Swing Trade Signals - Newser
Is a relief rally coming for Entera Bio Ltd. holders2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Does Entera Bio Ltd. show high probability of reboundJuly 2025 Pullbacks & Reliable Breakout Forecasts - Newser
Real time pattern detection on Entera Bio Ltd. stockJuly 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Is Entera Bio Ltd. still worth holding after the dipQuarterly Trade Review & Short-Term High Return Strategies - Newser
Leading vs lagging indicators on Entera Bio Ltd. performanceTrade Signal Summary & Technical Pattern Alert System - Newser
Entera Bio Ltd. stock trendline breakdownWeekly Trend Recap & Free Weekly Watchlist of Top Performers - Newser
Entera Bio Ltd. stock momentum explained2025 Performance Recap & Fast Entry High Yield Tips - Newser
Real time breakdown of Entera Bio Ltd. stock performanceJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Entera Bio Ltd Stock (ENTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):